Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,440 JPY | +2.06% | -4.06% | +1.34% |
18/04 | Nxera Pharma Initiates Restricted Stock Unit Plans, Starting with Shares Worth 164 Million Yen in Total in May | MT |
17/04 | Nxera Pharma's Neuro Drug NBI-1117568 Passed Preclinical Toxicity Test | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.34% | 81Cr | |
-1.62% | 8.92TCr | |
+1.32% | 4.05TCr | |
-15.48% | 3.28TCr | |
+64.13% | 2.62TCr | |
-22.14% | 1.45TCr | |
-7.68% | 1.31TCr | |
-44.07% | 1.16TCr | |
-13.06% | 1.15TCr | |
+4.94% | 881.83Cr |
- Stock Market
- Equities
- 4565 Stock
- News Nxera Pharma Co., Ltd.
- Sosei Group Inks Licensing and Collaboration Deal for $100 Million Cash, Other Payments